Orchid Pharma Limited
NSE:ORCHPHARMA.NS
784.9 (INR) • At close May 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q2 | 2018 Q2 | 2016 Q1 | 2014 Q2 | 2013 Q4 | 2013 Q2 | 2012 Q4 | 2009 Q4 | 2009 Q3 | 2009 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 2,173.425 | 2,226.986 | 2,444.061 | 2,171.021 | 2,205.91 | 1,987.553 | 1,829.198 | 2,099.008 | 1,597.603 | 1,652.496 | 1,309.877 | 1,781.323 | 1,613.765 | 1,277.357 | 923.129 | 1,195.597 | 1,027.84 | 1,085.531 | 1,191.636 | 1,115.226 | 1,294.633 | 1,316.346 | 1,354.199 | 1,424.798 | 2,093.415 | 2,563.329 | 3,772.5 | 2,681.567 | 3,305.481 | 4,519.175 | 2,716.782 | 3,214.845 | 3,448.315 |
| Cost of Revenue
| 1,247.916 | 1,311.604 | 1,502.544 | 1,468.466 | 1,219.389 | 1,223.301 | 1,120.677 | 1,424.756 | 956.005 | 1,003.195 | 697.985 | 1,425.797 | 924.296 | 713.129 | 478.378 | 897.845 | 596.239 | 394.788 | 511.067 | 892.901 | 561.635 | 559.467 | 657.642 | 596.877 | 1,132.173 | 1,278.674 | 1,833.821 | 1,354.389 | 1,570.826 | 2,075.366 | 3,105.748 | 2,678.784 | 2,751.085 |
| Gross Profit
| 925.509 | 915.382 | 941.517 | 702.555 | 986.521 | 764.252 | 708.521 | 674.252 | 641.598 | 649.301 | 611.892 | 355.526 | 689.469 | 564.228 | 444.751 | 297.752 | 431.601 | 690.743 | 680.569 | 222.325 | 732.998 | 756.879 | 696.557 | 827.921 | 961.242 | 1,284.655 | 1,938.679 | 1,327.178 | 1,734.655 | 2,443.809 | -388.966 | 536.061 | 697.23 |
| Gross Profit Ratio
| 0.426 | 0.411 | 0.385 | 0.324 | 0.447 | 0.385 | 0.387 | 0.321 | 0.402 | 0.393 | 0.467 | 0.2 | 0.427 | 0.442 | 0.482 | 0.249 | 0.42 | 0.636 | 0.571 | 0.199 | 0.566 | 0.575 | 0.514 | 0.581 | 0.459 | 0.501 | 0.514 | 0.495 | 0.525 | 0.541 | -0.143 | 0.167 | 0.202 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 70.937 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 306.634 | 0 | 220.01 | 424.946 | 0 | 0 | 0 | 349.498 | 641.598 | 0 | 0 | 339.848 | 0 | 0 | 0 | 139.72 | 0 | 0 | 0 | 210.343 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.3 | 0 |
| Other Expenses
| 0 | 698.254 | 0 | 0 | 284.098 | 764.252 | 708.521 | 0 | 0 | 648.714 | 611.892 | 0 | 689.469 | 564.228 | 444.751 | 92.134 | 431.601 | 690.743 | 680.569 | 0 | 732.998 | 756.879 | 696.557 | 827.921 | 961.242 | 1,887.797 | 2,446.368 | 1,573.769 | 1,734.655 | 1,952.885 | -13.065 | -4.65 | 823.872 |
| Operating Expenses
| 306.634 | 698.254 | 220.01 | 424.946 | 284.098 | 764.252 | 708.521 | 173.773 | 641.598 | 648.714 | 611.892 | 634.276 | 689.469 | 564.228 | 444.751 | 297.752 | 431.601 | 690.743 | 680.569 | 222.325 | 732.998 | 756.879 | 696.557 | 827.921 | 961.242 | 1,887.797 | 2,446.368 | 1,573.769 | 1,734.655 | 1,952.885 | -13.065 | 4.65 | 823.872 |
| Operating Income
| 618.875 | 217.128 | 240.48 | 204.984 | 702.423 | 588.659 | 144.348 | 342.041 | 393.014 | 0.587 | -91.801 | 30.159 | 311.483 | -87.614 | -205.426 | 65.898 | -321.912 | -120.17 | -103.478 | -240.695 | -314.221 | -326.031 | -435.985 | -261.867 | -98.711 | -603.142 | -507.689 | -246.591 | -1.118 | 490.924 | -375.901 | 531.411 | -126.642 |
| Operating Income Ratio
| 0.285 | 0.097 | 0.098 | 0.094 | 0.318 | 0.296 | 0.079 | 0.163 | 0.246 | 0 | -0.07 | 0.017 | 0.193 | -0.069 | -0.223 | 0.055 | -0.313 | -0.111 | -0.087 | -0.216 | -0.243 | -0.248 | -0.322 | -0.184 | -0.047 | -0.235 | -0.135 | -0.092 | -0 | 0.109 | -0.138 | 0.165 | -0.037 |
| Total Other Income Expenses Net
| -394.375 | 41.876 | 40.723 | 98.843 | -400.498 | -388.421 | -36.597 | 317.266 | -325.73 | -33.816 | -49.092 | -41.599 | -417.172 | -81.265 | -77.553 | -100.35 | -125.334 | -123.998 | -123.145 | -147.897 | 37.294 | 65.214 | 51.521 | 30.533 | -707.342 | 0 | -1,355.781 | -921.607 | -302.376 | -610.699 | 833.809 | -549.835 | -311.702 |
| Income Before Tax
| 224.5 | 259.004 | 281.203 | 303.827 | 301.925 | 200.238 | 107.751 | 659.307 | 67.284 | -33.229 | -140.893 | -11.44 | -105.689 | -168.879 | -282.979 | -34.452 | -447.246 | -244.168 | -226.623 | -388.592 | -276.927 | -260.817 | -384.464 | -231.334 | -806.053 | -603.142 | -1,863.47 | -1,168.198 | -303.494 | -119.775 | 457.908 | -18.424 | -438.344 |
| Income Before Tax Ratio
| 0.103 | 0.116 | 0.115 | 0.14 | 0.137 | 0.101 | 0.059 | 0.314 | 0.042 | -0.02 | -0.108 | -0.006 | -0.065 | -0.132 | -0.307 | -0.029 | -0.435 | -0.225 | -0.19 | -0.348 | -0.214 | -0.198 | -0.284 | -0.162 | -0.385 | -0.235 | -0.494 | -0.436 | -0.092 | -0.027 | 0.169 | -0.006 | -0.127 |
| Income Tax Expense
| 16.749 | 0 | -1.541 | -31.191 | 7.612 | 0 | 0 | 0.16 | -8.585 | 0 | 0 | 57.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.882 | 0 | 0 | 0 | -0.063 | -102.65 | -127.52 | 140.002 | 154.486 | -104.033 | -325.287 | 182.963 | 28.322 | -53.76 |
| Net Income
| 207.751 | 272.365 | 293.506 | 335.267 | 294.313 | 198.037 | 94.048 | 591.396 | 75.869 | -53.948 | -150.134 | -65.864 | -138.632 | 494.021 | -309.037 | -247.263 | -447.246 | -244.168 | -226.623 | -388.593 | -276.927 | -260.817 | -384.464 | -231.251 | -703.403 | -475.622 | -2,003.472 | -1,322.684 | -199.461 | 205.512 | 274.945 | -46.746 | -384.584 |
| Net Income Ratio
| 0.096 | 0.122 | 0.12 | 0.154 | 0.133 | 0.1 | 0.051 | 0.282 | 0.047 | -0.033 | -0.115 | -0.037 | -0.086 | 0.387 | -0.335 | -0.207 | -0.435 | -0.225 | -0.19 | -0.348 | -0.214 | -0.198 | -0.284 | -0.162 | -0.336 | -0.186 | -0.531 | -0.493 | -0.06 | 0.045 | 0.101 | -0.015 | -0.112 |
| EPS
| 4.1 | 5.37 | 5.79 | 6.81 | 6.18 | 4.3 | 1.85 | 14.49 | 1.86 | -1.32 | -3.68 | -1.61 | -3.4 | 12.1 | -7.57 | -6.06 | -10.96 | -5.98 | -5.55 | -9.52 | -6.78 | -2.93 | -4.32 | -2.6 | -7.91 | -5.58 | -28.44 | -18.77 | -2.83 | 2.92 | 4.01 | -0.68 | -5.4 |
| EPS Diluted
| 4.1 | 5.37 | 5.79 | 6.81 | 6.18 | 4.3 | 1.85 | 14.49 | 1.86 | -1.32 | -3.68 | -1.6 | -3.4 | 12.1 | -7.57 | -6.06 | -10.96 | -5.98 | -5.55 | -9.52 | -6.78 | -2.93 | -4.32 | -2.6 | -7.91 | -5.58 | -28.44 | -18.77 | -2.83 | 2.92 | 4.01 | -0.68 | -5.4 |
| EBITDA
| 348.525 | 378.548 | 400.626 | 422.767 | 430.05 | 316.693 | 240.28 | 806.266 | 225.9 | 236.625 | 153.803 | 299.312 | 164.371 | 130.722 | 26.933 | 287.677 | -31.984 | 188.63 | 205.708 | -68.79 | 72.419 | 57.231 | -70.764 | 98.174 | 284.842 | 474.686 | -207.012 | 139.75 | 856.72 | 895.061 | 1,370.017 | 693.943 | 194.876 |
| EBITDA Ratio
| 0.16 | 0.17 | 0.164 | 0.195 | 0.195 | 0.159 | 0.131 | 0.384 | 0.141 | 0.143 | 0.117 | 0.168 | 0.102 | 0.102 | 0.029 | 0.241 | -0.031 | 0.174 | 0.173 | -0.062 | 0.056 | 0.043 | -0.052 | 0.069 | 0.136 | 0.185 | -0.055 | 0.052 | 0.259 | 0.198 | 0.504 | 0.216 | 0.057 |